<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:mp ids='MP_0002079'>Hyperinsulinism</z:mp> is a cause of recurrent and severe <z:e sem="disease" ids="C0020615" disease_type="Disease or Syndrome" abbrv="">hypoglycaemia</z:e> in the newborn and infancy period </plain></SENT>
<SENT sid="1" pm="."><plain>Several developmental <z:e sem="disease" ids="C0567439" disease_type="Disease or Syndrome" abbrv="">genetic syndromes</z:e> are associated with <z:mp ids='MP_0002079'>hyperinsulinism</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>The underlying molecular mechanisms that lead to <z:hpo ids='HP_0000825'>hyperinsulinaemic hypoglycaemia</z:hpo> in most of these syndromes are unclear </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Beckwith-Wiedemann syndrome</z:e> (BWS) is the most common syndrome associated with <z:mp ids='MP_0002079'>hyperinsulinism</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>The incidence of <z:mp ids='MP_0002079'>hyperinsulinism</z:mp> in children with BWS is about 50% </plain></SENT>
<SENT sid="5" pm="."><plain>The <z:hpo ids='HP_0000825'>hyperinsulinaemic hypoglycaemia</z:hpo> can be transient, which, in the majority of infants, will be asymptomatic and resolve within the first few days of life </plain></SENT>
<SENT sid="6" pm="."><plain>Rarely patients with BWS may require a pancreatectomy </plain></SENT>
<SENT sid="7" pm="."><plain>Other <z:hpo ids='HP_0001548'>overgrowth</z:hpo> syndromes such as Soto's syndrome may overlap with BWS and present with <z:mp ids='MP_0002079'>hyperinsulinism</z:mp> </plain></SENT>
<SENT sid="8" pm="."><plain>Patients with other rare syndromes such as Costello, Timothy and <z:e sem="disease" ids="C0796004" disease_type="Disease or Syndrome" abbrv="">Kabuki syndromes</z:e> can present with <z:hpo ids='HP_0000825'>hyperinsulinaemic hypoglycaemia</z:hpo> but the genetic mechanism(s) that leads to dysregulated insulin secretion in these syndromes is(are) still unclear </plain></SENT>
<SENT sid="9" pm="."><plain>The <z:e sem="disease" ids="C0242354" disease_type="Disease or Syndrome" abbrv="">congenital disorders</z:e> of glycosylation (CDG) are a rapidly expanding group of <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndromes</z:e> with a wide symptomatology and severity </plain></SENT>
<SENT sid="10" pm="."><plain>They <z:hpo ids='HP_0000001'>all</z:hpo> stem from deficient N-glycosylation of proteins </plain></SENT>
<SENT sid="11" pm="."><plain>Hyper-insulinism has been described in <z:e sem="disease" ids="C0242354" disease_type="Disease or Syndrome" abbrv="">congenital disorders</z:e> of glycosylation, mostly in CDG-Ib but also as the leading symptom in a CDG-Ia patient </plain></SENT>
<SENT sid="12" pm="."><plain>In summary, <z:mp ids='MP_0002079'>hyperinsulinism</z:mp> may be associated with a large number of developmental syndromes however the underlying molecular mechanisms that cause <z:mp ids='MP_0002079'>hyperinsulinism</z:mp> in these syndromes are still unknown </plain></SENT>
</text></document>